Last reviewed: May 30, 2026 Last updated: May 30, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Kimberly Gudzune, medical director of the American Board of Obesity Medicine
Invest in your health, not just a prescription At Medi, youre not just paying for a shot
Maintenance shifts the focus to weight stability, hunger, strength, and laboratory results
How much weight can I expect to lose on tirzepatide niacinamide
Altogether, these findings suggest a powerful synergy: GLP1based medication paired with structured lifestyle changes may offer a dual approach to managing obesity while enhancing cardiovascular healthpotentially reshaping treatment strategies for chronic heart and metabolic conditions